drugset / Trial / NCT04269265
The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination
Phase 1/2
Completed
43 enrolled
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID) · collab
NaSingle-groupOpen-labelBasic science
Summary
Hypothesis: Infections other than HIV can cause LN inflammation and collagen damage to the fibroblastic reticular cell network (FRCn), which will lead to CD4 T cell depletion and impaired vaccine responses. This protocol will study yellow fever vaccine (YFV) in two cohorts of people, one from Uganda and the other from Minnesota where we collect lymphoid tissues (LT) and peripheral blood monocytes (PBMCs) before and after vaccination using a new technique to catalog infectious burden of the individual, determine the relationship between IA, Infections, and immune response.
Timeline
- Start
- 2020-07-01
- Primary completion
- 2023-10-23
- Completion
- 2023-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yellow Fever Vaccine | Vaccine | — | Subcutaneous |